Pelthos Therapeutics Inc. (PTHS)
NYSE: PTHS · Biological Products, (No Diagnostic Substances) · Durham, NC · filing with the SEC since 2022
Who runs Pelthos Therapeutics Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Plesha Scott M.
CEO and President. First filing Jul 2025, latest Apr 1, 2026, 0 filings in all.
Officers reporting now
4
of 12 people with a filing in the last fifteen months
Directors reporting now
8
14 people on the record since 2024
Officerssales are open-market, Oct 6, 2025 to Oct 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Francis Knuettel II | CFO, Treas & Secty | Feb 2024 | May 26, 2026 | 1 · $0.00 |
| Gay John M. | Chief Financial Officer | Apr 2026 | Apr 20, 2026 | none |
| Plesha Scott M. | CEO and President | Jul 2025 | Apr 1, 2026 | none |
| Rangarao Sai | Chief Commercial Officer | Jul 2025 | Apr 1, 2026 | none |
Directorssales are open-market, Oct 6, 2025 to Oct 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Friedberg Ezra M | director | Feb 2024 | Oct 6, 2026 | 11 · $300,000 |
| Greenleaf Peter | director | Jul 2025 | Oct 6, 2026 | 5 · $100,000 |
| Pauls Matthew | director | Jul 2025 | Oct 6, 2026 | 5 · $100,000 |
| Davis Todd C | director | Feb 2024 | Jun 15, 2026 | none |
| Malamut Richard | director | Feb 2024 | Apr 6, 2026 | 2 · $0.00 |
| Baxter Richard B | director | Jul 2025 | Apr 1, 2026 | none |
| Einhorn Andrew J. | director | Dec 2025 | Dec 29, 2025 | none |
| Ligand Pharmaceuticals Inc | director | Jul 2025 | Dec 19, 2025 | none |
Earlier names on the record7, newest filing first
Simmons Chia-Lin · director · last filing Apr 2025Lang Eric · officer · last filing Jun 2024Ame Equities LLC · 10% owner · last filing Feb 2024Aperture Healthcare Ventures Ltd. · 10% owner · last filing Feb 2024Balmoral Financial Group LLC · 10% owner · last filing Feb 2024Boswell Prayer Ltd. · 10% owner · last filing Feb 2024Motif Pharmaceuticals Ltd. · 10% owner · last filing Feb 2024
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.